The long, long awaited 2018 Midterm elections have come and (mostly) gone. As you’ve probably heard, the Democrats have gained control of the House of Representatives, while the Republicans have increased their majority in the Senate. But what does this mean for science here in Washington? Find out more in this article.

Though it required negotiations that stretched nearly seven months into the fiscal year it is designed to fund, the FY 2018 Omnibus Appropriations act won the approval of a sizable majority in Congress and the reluctant approval of the President at the end of March, providing substantial boosts in Federal spending, including healthy increases to science investments across the government.

Passage of the omnibus bill was made possible by an agreement in February to increase statutory limits on discretionary spending for FY 2018 and FY 2019. That extra spending room ensured that congressional appropriators could boost military spending sufficiently to satisfy a majority of the GOP and increased non-defense spending sufficiently to woo enough congressional Democrats to overcome opposition from the conservative Freedom Caucus in the House. In the end, the 2,000+ page bill boosts Federal discretionary spending to $1.3 trillion in FY 18, and boosts Federal R&D efforts by nearly 13 percent.

While appropriators generally do not spread funding increases evenly throughout the bill, overall, science agencies fare well in the bill, in many cases receiving meaningful increases for the first time in several years.